Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H13NO |
Molecular Weight | 211.2591 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=CC=C1\C=N\CC2=CC=CC=C2
InChI
InChIKey=LPSMMAHYAIVSQW-RVDMUPIBSA-N
InChI=1S/C14H13NO/c16-14-9-5-4-8-13(14)11-15-10-12-6-2-1-3-7-12/h1-9,11,16H,10H2/b15-11+
Norletimol is a Schiff base with promising anti-inflammatory properties. The time taken for elimination of 50% of the Norletimol dose in the urine was approximately five hours. As an antirheumatic agent it was tested in clinical trials in Iraq. It was used in progressive myopia in children.
Originator
Approval Year
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
Drug as perpetrator​
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
inconclusive [IC50 38.9018 uM] | ||||
no | ||||
no | ||||
yes [IC50 14.1254 uM] |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no |
Tox targets
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6858201
Rat: 50, 100 and 300 mg/kg
Dog: 44, 85 and 300 mg/kg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C308
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C90814
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
4315
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
128931
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
129855-29-4
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
7515-02-8
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
ALTERNATIVE | |||
|
100000083599
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
886-08-8
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
C019083
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
SUB09373MIG
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL1881591
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
FB45669IEG
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
5381977
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY | |||
|
DTXSID7046174
Created by
admin on Fri Dec 15 16:21:55 GMT 2023 , Edited by admin on Fri Dec 15 16:21:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY